With the number of deaths related to an outbreak of fungal meningitis now at 24, Senators overseeing drug safety and control policies continue to investigate what went wrong at a Massachusetts compounding pharmacy prior to the distribution of potentially thousands of compromised doses of a steroid used to treat back pain. Most recently, Senate HELP Committee members, led by Chairman Harkin (D-IA) and Ranking Member Enzi (R-WY) sent letters to the New England Compounding Center, the Massachusetts Board of Pharmacy and the FDA seeking information regarding how the outbreak occurred and what warning signs may have existed to inform the committee's oversight of this situation, and to assist in efforts to determine if further federal authorities are needed. Last week, the Massachusetts Board of Pharmacy permanently revoked the license of the New England Compounding Center, the facility implicated in a nationwide outbreak of fungal meningitis.